Rein Therapeutics (015A) Q2 2024 Earnings Report
DE:015A Q2 2024 EPS Results
- Actual EPS
- -EUR 0.40
- Consensus EPS
- -EUR 0.20
- Beat/Miss
- Missed by -EUR 0.20
- One Year Ago EPS
- -EUR 0.35
DE:015A Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/14/2024
- Time
- After Close
- Conference Call
- Wednesday, August 14, 2024
DE:015A Upcoming Earnings
Rein Therapeutics's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:015A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | -0.09- | -0.19 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -0.15-0.09 | -0.25 | 64.29% (+0.16) | |
| May 20, 2026 | 2026 (Q1) | ―- | -0.22 | ― | |
| Apr 06, 2026 | 2025 (Q4) | -0.44-0.17 | -0.22 | 24.00% (+0.05) | |
| Nov 14, 2025 | 2025 (Q3) | -0.21-0.19 | -0.24 | 22.22% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -0.20-0.25 | -0.4 | 37.33% (+0.15) | |
| May 15, 2025 | 2025 (Q1) | ―-0.22 | -0.77 | 70.93% (+0.55) | |
| Apr 07, 2025 | 2024 (Q4) | -0.19-0.22 | -0.77 | 70.93% (+0.55) | |
| Nov 14, 2024 | 2024 (Q3) | -0.22-0.24 | -0.36 | 32.50% (+0.12) | |
| Aug 14, 2024 | 2024 (Q2) | -0.20-0.40 | -0.35 | -14.21% (-0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
